Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management

Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management

Abstract This concise review summarizes results of the latest clinical trials that support the use of standardized cranberry juice intake as a complementary means of suppressing Helicobacter pylori infections. While not a replacement for antibiotic therapies, this tolerable and accessible dietary ap...

Full description

Bibliographic Details
Main Author: Amy B. Howell
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Food Frontiers
Subjects:
antibiotic resistance
clinical trials
Cranberry
Helicobacter pylori
stomach cancer
suppression
Online Access:https://doi.org/10.1002/fft2.47
id doaj-48221d1782624082a1ca6a196fb66c17
record_format Article
spelling doaj-48221d1782624082a1ca6a196fb66c172020-11-25T03:59:16ZengWileyFood Frontiers2643-84292020-09-011332933110.1002/fft2.47Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori managementAmy B. Howell0Marucci Center for Blueberry Cranberry Research, Rutgers The State University of New Jersey Chatsworth New JerseyAbstract This concise review summarizes results of the latest clinical trials that support the use of standardized cranberry juice intake as a complementary means of suppressing Helicobacter pylori infections. While not a replacement for antibiotic therapies, this tolerable and accessible dietary approach to help reduce inoculum levels in high‐risk populations could help curb infections and potentially reduce antibiotic use and subsequent stomach cancer prevalence.https://doi.org/10.1002/fft2.47antibiotic resistanceclinical trialsCranberryHelicobacter pyloristomach cancersuppression
collection DOAJ
language English
format Article
sources DOAJ
author Amy B. Howell
spellingShingle Amy B. Howell
Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
Food Frontiers
antibiotic resistance
clinical trials
Cranberry
Helicobacter pylori
stomach cancer
suppression
author_facet Amy B. Howell
author_sort Amy B. Howell
title Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
title_short Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
title_full Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
title_fullStr Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
title_full_unstemmed Clinical evidence supporting cranberry as a complementary approach to Helicobacter pylori management
title_sort clinical evidence supporting cranberry as a complementary approach to helicobacter pylori management
publisher Wiley
series Food Frontiers
issn 2643-8429
publishDate 2020-09-01
description Abstract This concise review summarizes results of the latest clinical trials that support the use of standardized cranberry juice intake as a complementary means of suppressing Helicobacter pylori infections. While not a replacement for antibiotic therapies, this tolerable and accessible dietary approach to help reduce inoculum levels in high‐risk populations could help curb infections and potentially reduce antibiotic use and subsequent stomach cancer prevalence.
topic antibiotic resistance
clinical trials
Cranberry
Helicobacter pylori
stomach cancer
suppression
url https://doi.org/10.1002/fft2.47
work_keys_str_mv AT amybhowell clinicalevidencesupportingcranberryasacomplementaryapproachtohelicobacterpylorimanagement
_version_ 1724454913169162240

Similar Items